46 filings
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
POS EX
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Additional exhibits for listing
6:09pm
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
424B3
k6nkkczyzb7f0cz6q
16 Apr 24
Prospectus supplement
5:45pm
10-K
nk6o hkd0sj
16 Apr 24
Annual report
4:48pm
S-8
e1ld0 3l5gocpg
12 Apr 24
Registration of securities for employees
7:22pm
8-K
e9df8wxsgc2xi
9 Apr 24
Chromocell Issues Letter to Stockholders from Chief Executive Officer
8:30am
NT 10-K
xko5t5i1
1 Apr 24
Notice of late annual filing
9:00am
8-K
jg0fa7l
21 Mar 24
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
9:00am
8-K
x9df7auc i4
18 Mar 24
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
4:05pm
8-K
d88hb 4izi
13 Mar 24
Regulation FD Disclosure
8:00am
8-K
k8j863o7za2igfw
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
b6q3xy6lj9iqfkrx
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
gg8q0bfhl4s14w6 wml
20 Feb 24
Prospectus supplement with pricing info
5:28pm
SEC STAFF
8mt1ygn1vyu
20 Feb 24
SEC staff action: Order
12:00am
POS EX
un2rnivorgn1ld6
15 Feb 24
Additional exhibits for listing
9:56pm
CERT
8hhq9c9b7kd d368
15 Feb 24
Certification of approval for exchange listing
11:46am
8-A12B
2ktxw2h
15 Feb 24
Registration of securities on exchange
11:35am